StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Hydrochloric Acid → 1-Methyl-4-(vinylsulfonyl)piperazine

HRID 272551
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 272551
C1C2[C:10]3=[CH:12]C4C=CC(C(N)=O)=[CH:17][C:18]=4[N:9]3[CH2:8]C=CC=2C=CC=1.C1C2C3=CC4C=C[C:37]([C:40](O)=O)=CC=4N3CC=CC=2C=CC=1.[OH-].[Na+].Cl.C(Cl)(=O)C(Cl)=O.CCN(P1(N(C)CCCN1C)=NC(C)(C)C)CC.C[NH:71][S:72](NC)(=[O:74])=[O:73]>C(Cl)Cl.CO.C1COCC1>[CH3:8][N:9]1[CH2:10][CH2:12][N:71]([S:72]([CH:37]=[CH2:40])(=[O:74])=[O:73])[CH2:17][CH2:18]1
KomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

10

Edukt 7

HCID 313Hydrochloric Acid2×HCID 14798Sodium HydroxideHCID 65578Oxalyl chlorideHCID 89736N,N'-DimethylsulfamideHCID 35138512-((1,1-Dimethylethyl)imino)-N,N-diethylhexahydro-1,3-dimethyl-2lambda5-1,3,2-diazaphosphorin-2-amineHCID 666396797H-indolo[2,1-a][2]benzazepine-10-carboxylic acid
HCID 666396907H-indolo[2,1-a][2]benzazepine-10-carboxamide

Produkt 1

HCID 598375801-Methyl-4-(vinylsulfonyl)piperazineAusbeute 68 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 6344DichloromethaneLösungsmittel2×HCID 21899815MeOH tetrahydrofuranLösungsmittel

Reaktionsbedingungen

Temperatur
22 °C

Versuchsvorschrift

7H-Indolo[2,1-a][2]benzazepine-10-carboxamide, 13-cyclohexyl-N-[(dimethylamino)sulfonyl]-3-methoxy-6-[(4-methyl-1-piperazinyl)sulfonyl]-. To a solution of 7H-Indolo[2,1-a][2]benzazepine-10-carboxylic acid, 13-cyclohexyl-3-methoxy-6-[(4-methyl-1-piperazinyl)sulfonyl]-, methyl ester (60 mg, 0.11 mmol) in 1:1 MeOH/THF (2.0 mL) was added 1M NaOH (2.0 mL). The resulting mixture was stirred at 22° C. for 16 hr. 1M HCl (15 mL) was added and the aqueous layer was extracted with CHCl3 (2×15 mL). The organic phase was dried over Na2SO4, filtered, and concentrated under reduced pressure to afford a white solid. This solid was dissolved in CH2Cl2 (110 mL) and 2M oxalyl chloride (1.0 mL) in CH2Cl2 was added. This solution was stirred at 22° C. for 2 hr and concentrated under reduced pressure. The resulting yellow oil was redissolved in CH2Cl2 (110 mL); BEMP (60 mg, 0.22 mmol) and dimethylsulfamide (68 mg, 0.55 mmol) were added. The resulting mixture was allowed to stir at 22° C. for 6 hr. 1M HCl (15 mL) was added and the aqueous layer was extracted with CHCl3 (2×30 mL). The organic phase was concentrated under reduced pressure. This oil was purified by reverse-phase prep HPLC to afford the title compound (48 mg, 68%) as a yellow paste. MS m/z 643 (MH+). 1H NMR (300 MHz, CDCl3) δ ppm 1.13-1.52 (m, 4H), 1.79 (m, 1H), 1.90-2.11 (m, 5H), 2.56 (s, 3H), 2.79 (m, 1H), 2.87-3.16 (m, 5H), 3.05 (s, 6H), 3.36 (m, 1H), 3.58 (m, 1H), 3.70 (m, 1H), 3.92 (s, 3H), 4.41 (broad d, 1H), 5.28 (broad d, 1H), 7.01 (d, 1H), 7.12 (m, 1H), 7.52 (m, 2H), 7.65 (s, 1H), 7.89 (m, 1H), 8.10 (s, 1H), 9.60 (s, 1H).

Aufarbeitung

  1. extractionthe aqueous layer was extracted with CHCl3 (2×15 mL)
  2. dry with materialThe organic phase was dried over Na2SO4
  3. filtrationfiltered
  4. concentrationconcentrated under reduced pressure
  5. customto afford a white solid
  6. stirringThis solution was stirred at 22° C. for 2 hr
  7. concentrationconcentrated under reduced pressure
  8. dissolutionThe resulting yellow oil was redissolved in CH2Cl2 (110 mL)
  9. stirringto stir at 22° C. for 6 hr
  10. extractionthe aqueous layer was extracted with CHCl3 (2×30 mL)
  11. concentrationThe organic phase was concentrated under reduced pressure
  12. customThis oil was purified by reverse-phase prep HPLC

Quellen und Nachweise

ORD-Eintrag
ord-b89676e591234712922f7f7a73bacaf1
Quelldatensatz
uspto-grants-2008_11
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US07456167B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion